Medi-sulting Topical Pain Relief
NDC Package 76074-123-21

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Medi-sulting Topical Pain Relief is uSES: FOR THE TEMPORARY RELIEF OF MINOR ACHES AND PAINS OF MUSCLES AND JOINTS ASSOCIATED WITH ARTHRITIS, SIMPLE BACKACHE, STRAINS, SPRAINS, MUSCLE SORENESS AND STIFFNESS. Marketed by Two Hip Consulting, Llc, this product is identified by NDC 76074-123 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
76074-123-21
Package Description
10 g in 1 PATCH
Product Code
76074-123
11-Digit Billing Format
76074012321
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1356803 - capsaicin 0.035 % / lidocaine HCl 0.5 % / menthol 5 % / methyl salicylate 20 % Medicated Patch
  • RxCUI: 1356803 - capsaicin 0.00035 MG/MG / lidocaine hydrochloride 0.005 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Medicated Patch

Clinical Specifications

Proprietary Name
Medi-sulting Topical Pain Relief
Dosage Form
-
Usage Information
USES: FOR THE TEMPORARY RELIEF OF MINOR ACHES AND PAINS OF MUSCLES AND JOINTS ASSOCIATED WITH ARTHRITIS, SIMPLE BACKACHE, STRAINS, SPRAINS, MUSCLE SORENESS AND STIFFNESS.

Regulatory & Marketing

Labeler Name
Two Hip Consulting, Llc
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
08-18-2012
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76074-123-21 identifies a specific commercial package of 10 g in 1 patch of Medi-sulting Topical Pain Relief, labeled by Two Hip Consulting, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Two Hip Consulting, Llc on August 18, 2012. The current certification is valid through December 31, 2020.

How is this Two Hip Consulting, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76074012321. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76074-123-21
11-Digit CMS (5-4-2)
76074-0123-21

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.